ResearcherTianjin Medical UniversityActive in the last 2 years

Xiao-Chuan Duan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5677-8135; OpenAlex author ID A5022164856. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

Drug-repurposing by virtual and experimental screening of PFKFB3 inhibitors for pancreatic cancer therapy. Last author DOI 10.1016/j.ejphar.2024.176330 ↗
Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy. Last author DOI 10.2147/ijn.s404848 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhi-Xin Zhong · 2 shared papers, 2023–2024 · strength 0.41
- Paper Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancre… DOI 10.2147/ijn.s404848 ↗
- Paper Drug-repurposing by virtual and experimental screening of PFKFB3 inhibitors for pancreatic cancer therapy. DOI 10.1016/j.ejphar.2024.176330 ↗
Xin Cao · 1 shared paper, 2024 · strength 0.20
- Paper Drug-repurposing by virtual and experimental screening of PFKFB3 inhibitors for pancreatic cancer therapy. DOI 10.1016/j.ejphar.2024.176330 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.